Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Paul Kim
AddedMar 31, 2024
UpdatedMay 1, 2026
Paul Kim

Paul Kim

Board Member, Exagen

Paul Kim's Career

Exagen
Exagen

Vista, CA, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Paul Kim's Career

Exagen
Exagen
Public$322.6M2042002Vista, CA, US
Board Member· Board

Leadership at Exagen

Ana HookerAna HookerBoard Member
John AballiJohn AballiCEO
Tina NovaTina NovaBoard Member
Brian BirkBrian BirkBoard Member
Bruce RobertsonBruce RobertsonBoard Member
Andrew ConcoffAndrew ConcoffBoard Member

Similar to Exagen

Quest DiagnosticsQuest DiagnosticsSecaucus, NJ, USMedical Testingest. 1967Quest DiagnosticsSecaucus, NJ, US · est. 1967

Quest Diagnostics: A national medical research company providing comprehensive diagnostic testing and services.

Public · $750M49k
InvitaeInvitaeSan Francisco, CA, USGenetic Testingest. 2010InvitaeSan Francisco, CA, US · est. 2010

Invitae Corp., a global genetic information company, specializes in diagnostics, oncology, pediatrics, and hereditary screening.

Public · $2.5B1.7k
Progentec DiagnosticsProgentec DiagnosticsOklahoma City, OK, USBiomarkers, Diagnosticsest. 2015Progentec DiagnosticsOklahoma City, OK, US · est. 2015

Progentec: Pioneering next-gen diagnostics and digital biomarkers for enhanced autoimmune disease care.

Public · $6.3M14
SenGenixSenGenixDurham, NC, USDiagnostic Testsest. 2012SenGenixDurham, NC, US · est. 2012

SenGenix: Developing fast, accurate, low-cost point-of-care diagnostic tests since 2012.

Series A · $11.2M6

Paul Kim's Similar Executives & Operators

Jay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakSoemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakLau Eng BoonLau Eng BoonBoard Member · BukalapakWILL WEI CHENGWILL WEI CHENGBoard Member · DiDiDhirubhai H. AmbaniDhirubhai H. AmbaniBoard Member · Reliance RetailMason YeoMason YeoBoard Member · KakaoJaeHong ChoiJaeHong ChoiBoard Member · KakaoYun SeokYun SeokBoard Member · Kakao

People Similar to Paul Kim

Hsieh MingHsieh MingBoard Member · Cogent Communications HoldingsJames JianJames JianCo-Founder · Fulgent GeneticsSusan KimSusan KimBoard Member · Pivot BioPaul MarianiPaul MarianiBoard Member · GalvanizeSapna SrivastavaSapna SrivastavaBoard Member · SQZ BiotechnologiesG. Bradley ColeG. Bradley ColeBoard Member · Kiniksa Pharmaceuticals